Covered recipient · General Payments record
MAMI TROLLOPE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2024
$353.94
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $314.38 | 14 |
| Education | $39.56 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $60.63 | 2 |
| Madrigal Pharmaceuticals | $39.56 | 1 |
| SANOFI-AVENTIS U.S. LLC | $27.77 | 1 |
| MannKind Corporation | $25.78 | 1 |
| IBSA Pharma Inc. | $24.69 | 1 |
| ABBVIE INC. | $23.09 | 1 |
| Radius Health, Inc. | $22.36 | 1 |
| Verity Pharmaceuticals Inc. | $20.75 | 1 |
| Amgen Inc. | $20.28 | 1 |
| Novo Nordisk AS | $19.32 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $18.85 | 1 |
| Corcept Therapeutics | $17.35 | 1 |
| Medtronic, Inc. | $16.92 | 1 |
| Insulet Corporation | $16.59 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $353.94 | 15 |
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.09 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108328798 | CMS |
| Amgen Inc. | $20.28 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117402192 | CMS |
| Corcept Therapeutics | $17.35 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117778837 | CMS |
| IBSA Pharma Inc. | $24.69 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142974387 | CMS |
| Insulet Corporation | $16.59 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116820590 | CMS |
| Lilly USA, LLC | $29.79 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135808835 | CMS |
| Lilly USA, LLC | $30.84 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135831415 | CMS |
| Madrigal Pharmaceuticals | $39.56 | 10/04/2024 | Education | Undisputed | 01/23/2026 | 1144199893 | CMS |
| Mannkind Corporation | $25.78 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145862819 | CMS |
| Medtronic, Inc. | $16.92 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116966252 | CMS |
| Novo Nordisk Inc | $19.32 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100590426 | CMS |
| Radius Health, Inc. | $22.36 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1090031731 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $18.85 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139171082 | CMS |
| SANOFI-AVENTIS U.S. LLC | $27.77 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139933075 | CMS |
| Verity Pharmaceuticals Inc. | $20.75 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080614780 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.